Table 5 Comparison of total participants with impaired fasting plasma at the baseline and end of the study across intervention and control group.
Study | Study period (months) | Total participant with impaired fasting plasma glucose (mmol/L) at baseline | Total participant with impaired fasting plasma glucose (mmol/L) after 2 year | ||
|---|---|---|---|---|---|
Intervention group (n = 4063) | Control group (n = 4070) | Intervention group (n = 717) | Control group (n = 712) | ||
Fottrell et al.21 | 18 | 186 (5%) | 200(5%) | 315 (43.9%) | 337 (47.3%) |
